Sign in
4

Changes in Ownership

Candel Therapeutics, Inc. Filed Acc 0001209191-22-051131

Options or other derivatives

  • Chief Financial Officer acquired 230,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Amello Jason Chief Financial Officer 2022-09-21 Grant or award · Stock Option (Right to Buy) +230,000 230,000 D
Loading xslF345X03/doc4.xml…